Kevin D Bauer, MD
Cardiovascular Disease (Cardiology) · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 2
- Since medical school
- 18 years
- New York Medical College, 2008
Offices
2 locations · Washington Township Hospital District · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bauer’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A110953 · Current
Licensed to practise in California · since 2010 · expires 2027-11-30 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$215,950
Medicare paid this office $215,950 for 1,292 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 365 | $57,552 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 282 | $53,371 | $189 |
| Long return visit (40+ min) | 126 | $27,249 | $147 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 58 | $13,540 | $233 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 27 | $12,542 | $465 |
See all 26 services
| Return visit (30+ min) | 365 | $57,552 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 282 | $53,371 | $189 |
| Long return visit (40+ min) | 126 | $27,249 | $147 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 58 | $13,540 | $233 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 27 | $12,542 | $465 |
| New patient visit (60+ min) | 32 | $6,028 | $188 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 390 | $4,944 | $12 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 245 | $3,943 | $15 |
| Heart muscle strain imaging | 100 | $3,902 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $3,788 | $105 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 151 | $3,389 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 43 | $2,733 | $61 |
| Short return visit (20+ min) | 27 | $2,221 | $79 |
| Heart rhythm recording of continous external ekg over 8-15 days | 147 | $1,853 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 29 | $1,761 | $61 |
| Ultrasound of heart, follow-up | 15 | $1,756 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $1,752 | $125 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $1,702 | $61 |
| 3d radiographic procedure | 44 | $1,153 | $26 |
| Injection, perflutren lipid microspheres, per ml | 20 | $1,064 | $33 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 17 | $704 | $41 |
| Injection, regadenoson, 0.1 mg | 24 | $531 | None |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 13 | $478 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $477 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $447 | $26 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 26 | $428 | $8 |
Who their Medicare patients are
1,292 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 15% · Women 53% · Also on Medicaid 18% · Health risk score 1.17. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 41% · Diabetes 34% · Atrial fibrillation 29% · Chronic kidney disease 26% · Heart failure 20% · Cancer 15% · Depression 14% · COPD 10% · Dementia 6% · Stroke 6%.
The office billed $1,020,263, Medicare allowed $295,109 and paid $215,950; for 2,878 services of 47 kinds; $2,219 of it was for drugs given in the office and $213,730 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,292 | 2,878 | 76 | 1.17 | $1,020,263 | $215,950 |
| 2023 | 1,118 | 2,343 | 77 | 1.20 | $881,869 | $203,419 |
| 2022 | 1,105 | 2,431 | 76 | 1.14 | $926,942 | $233,554 |
| 2021 | 1,315 | 3,115 | 76 | 1.19 | $1,137,374 | $279,501 |
| 2020 | 1,133 | 2,635 | 76 | 1.31 | $898,746 | $217,362 |
| 2019 | 1,384 | 3,147 | 76 | 1.37 | $1,143,336 | $266,352 |
| 2018 | 1,287 | 3,114 | 75 | 1.43 | $1,098,242 | $256,381 |
| 2017 | 1,411 | 2,736 | 76 | 1.33 | $990,717 | $251,699 |
| 2016 | 1,205 | 2,119 | 76 | 1.24 | $747,241 | $198,102 |
| 2015 | 451 | 993 | 76 | 1.31 | $403,688 | $122,359 |
| 2014 | 53 | 83 | 75 | 1.37 | $30,292 | $9,378 |
| 2013 | 60 | 99 | 81 | 3.24 | $39,360 | $11,425 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Return visit (30+ min) | 317 | $51,221 | $106 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 210 | $40,479 | $191 |
| Long return visit (40+ min) | 135 | $31,192 | $153 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 27 | $12,700 | $470 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 50 | $11,568 | $231 |
| New patient visit (60+ min) | 48 | $9,370 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $7,448 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 364 | $4,727 | $12 |
| Injection, regadenoson, 0.1 mg | 23 | $3,778 | None |
| Heart muscle strain imaging | 74 | $2,929 | $39 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $2,639 | $176 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 41 | $2,503 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,459 | $154 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $2,234 | $66 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 88 | $2,071 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 29 | $1,798 | $62 |
| Injection, perflutren lipid microspheres, per ml | 20 | $1,220 | $36 |
| Heart rhythm recording of continous external ekg over 8-15 days | 87 | $1,096 | $13 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 14 | $1,061 | $76 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 24 | $966 | $20 |
| 3d radiographic procedure | 28 | $719 | $25 |
| Administration of influenza virus vaccine | 14 | $520 | $37 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $512 | $26 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | $464 | $29 |
2022: 25 services
| Return visit (30+ min) | 341 | $54,384 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 240 | $45,289 | $187 |
| Long return visit (40+ min) | 139 | $31,633 | $157 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 30 | $15,508 | $263 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $14,868 | $480 |
| New patient visit (60+ min) | 61 | $12,259 | $201 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $6,788 | $226 |
| Heart muscle strain imaging | 168 | $6,730 | $40 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 30 | $5,400 | $180 |
| Injection, regadenoson, 0.1 mg | 27 | $5,242 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,236 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 292 | $3,632 | $12 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,587 | $179 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 42 | $2,688 | $63 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 88 | $2,140 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $2,120 | $71 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 30 | $2,108 | $70 |
| 3d radiographic procedure | 90 | $2,094 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 31 | $1,820 | $59 |
| Injection, perflutren lipid microspheres, per ml | 22 | $1,490 | $36 |
| Heart rhythm recording of continous external ekg over 8-15 days | 85 | $1,258 | $15 |
| Administration of influenza virus vaccine | 31 | $1,137 | $37 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $605 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $411 | $26 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $354 | $24 |
2021: 25 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 312 | $62,331 | $197 |
| Return visit (30+ min) | 288 | $46,098 | $106 |
| Long return visit (40+ min) | 157 | $38,764 | $158 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $25,350 | $507 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 54 | $12,730 | $236 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $11,215 | $93 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 48 | $9,414 | $98 |
| Injection, regadenoson, 0.1 mg | 47 | $8,945 | None |
| New patient visit (60+ min) | 42 | $8,005 | $191 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 41 | $7,924 | $193 |
| Heart muscle strain imaging | 141 | $5,940 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 398 | $5,294 | $12 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,381 | $175 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 50 | $3,872 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $3,446 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 55 | $3,420 | $62 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 104 | $2,632 | $21 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 80 | $1,982 | $24 |
| 3d radiographic procedure | 80 | $1,867 | $23 |
| 3d radiographic procedure with computerized image postprocessing | 26 | $1,845 | $71 |
| Heart rhythm recording of continous external ekg over 8-15 days | 73 | $1,131 | $15 |
| Blood test, clotting time | 69 | $768 | $4 |
| Injection, perflutren lipid microspheres, per ml | 11 | $639 | $36 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $456 | $27 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $272 | $17 |
2020: 30 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | $46,626 | $200 |
| Return visit (30+ min) | 301 | $38,102 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 41 | $20,573 | $502 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 64 | $14,595 | $228 |
| Critical care, first 30-74 minutes | 17 | $10,956 | $196 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 42 | $8,116 | $97 |
| Injection, regadenoson, 0.1 mg | 36 | $6,802 | None |
| Long return visit (40+ min) | 39 | $6,726 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $6,528 | $93 |
| New patient visit (45+ min) | 40 | $5,700 | $142 |
| Short return visit (20+ min) | 84 | $5,653 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 322 | $5,108 | $15 |
| Telephone medical discussion with physician, 11-20 minutes | 62 | $4,548 | $68 |
| 3d radiographic procedure with computerized image postprocessing | 59 | $4,241 | $72 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 48 | $3,751 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,740 | $178 |
| Heart muscle strain imaging | 79 | $3,292 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 42 | $2,610 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $2,346 | $67 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 56 | $1,382 | $25 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,255 | $105 |
| Influenza vaccine split virus, preservative free | 20 | $1,205 | $60 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 41 | $1,195 | $21 |
| External ekg recording for more than 48 hours up to 21 days | 42 | $1,175 | $28 |
| Blood test, clotting time | 84 | $916 | $4 |
| Injection, perflutren lipid microspheres, per ml | 11 | $802 | $38 |
| 3d radiographic procedure | 28 | $650 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $561 | $37 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $520 | $26 |
| Administration of influenza virus vaccine | 20 | $411 | $21 |
2019: 29 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 354 | $71,021 | $199 |
| Return visit (30+ min) | 335 | $58,859 | $89 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 99 | $22,560 | $228 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $21,449 | $487 |
| New patient visit (45+ min) | 64 | $9,187 | $144 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $8,427 | $96 |
| Injection, regadenoson, 0.1 mg | 38 | $6,834 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $6,693 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 433 | $6,676 | $14 |
| Long return visit (40+ min) | 47 | $6,482 | $116 |
| 3d radiographic procedure with computerized image postprocessing | 83 | $5,760 | $69 |
| Short return visit (20+ min) | 72 | $5,307 | $62 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 57 | $4,552 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 57 | $3,959 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,351 | $168 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 51 | $3,084 | $60 |
| New patient visit (60+ min) | 12 | $2,171 | $181 |
| Influenza vaccine split virus, preservative free | 36 | $1,905 | $53 |
| External ekg recording for more than 48 hours up to 21 days | 65 | $1,820 | $28 |
| Ultrasound of heart, follow-up | 17 | $1,623 | $95 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 65 | $1,606 | $24 |
| 3d radiographic procedure | 61 | $1,393 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $1,168 | $20 |
| Blood test, clotting time | 83 | $884 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $779 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $720 | $40 |
| Administration of influenza virus vaccine | 34 | $686 | $20 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $415 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $227 | $13 |
2018: 28 services
| Return visit (30+ min) | 338 | $63,039 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 281 | $55,475 | $192 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 99 | $21,539 | $218 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $21,366 | $486 |
| Critical care, first 30-74 minutes | 18 | $9,793 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $9,023 | $88 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $8,056 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,500 | $174 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 481 | $7,131 | $14 |
| Long return visit (40+ min) | 49 | $6,604 | $116 |
| Injection, regadenoson, 0.1 mg | 36 | $6,288 | None |
| New patient visit (45+ min) | 42 | $5,817 | $139 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $4,093 | $64 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 44 | $3,448 | $77 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 50 | $2,897 | $58 |
| New patient visit (60+ min) | 16 | $2,887 | $180 |
| Short return visit (20+ min) | 37 | $2,695 | $60 |
| 3d radiographic procedure with computerized image postprocessing | 40 | $2,641 | $66 |
| Ultrasound of heart, follow-up | 23 | $2,507 | $104 |
| External ekg recording for more than 48 hours up to 21 days | 59 | $1,498 | $25 |
| Influenza vaccine split virus, preservative free | 30 | $1,316 | $44 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 59 | $1,313 | $22 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 37 | $1,187 | $18 |
| Blood test, clotting time | 70 | $955 | $5 |
| Administration of influenza virus vaccine | 30 | $759 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $676 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 22 | $621 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $168 | $13 |
2017: 26 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 332 | $71,079 | $212 |
| Return visit (30+ min) | 273 | $51,028 | $84 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 153 | $38,936 | $253 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 28 | $13,259 | $474 |
| New patient visit (45+ min) | 76 | $9,301 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $9,299 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,078 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 444 | $6,361 | $14 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 28 | $5,183 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 60 | $4,887 | $80 |
| Long return visit (40+ min) | 31 | $3,953 | $110 |
| Short return visit (20+ min) | 60 | $3,727 | $52 |
| New patient visit (60+ min) | 21 | $3,546 | $169 |
| Injection, regadenoson, 0.1 mg | 18 | $2,862 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 35 | $2,214 | $63 |
| Ultrasound of heart, follow-up | 14 | $1,860 | $116 |
| Influenza vaccine split virus, preservative free | 35 | $1,544 | $44 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,227 | $82 |
| Administration of influenza virus vaccine | 37 | $1,182 | $31 |
| Blood test, clotting time | 98 | $1,156 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 45 | $1,014 | $17 |
| External ekg recording for more than 48 hours up to 21 days | 30 | $839 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 30 | $730 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $243 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $196 | $13 |
| Injection, dobutamine hydrochloride, per 250 mg | 11 | $48 | None |
2016: 22 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 281 | $62,751 | $219 |
| Return visit (30+ min) | 179 | $31,678 | $92 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 108 | $27,934 | $256 |
| New patient visit (45+ min) | 97 | $13,529 | $139 |
| Short return visit (20+ min) | 150 | $12,569 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 408 | $6,156 | $15 |
| Critical care, first 30-74 minutes | 15 | $5,833 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $5,815 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,364 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $5,091 | $89 |
| Long return visit (40+ min) | 37 | $4,239 | $112 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 45 | $3,536 | $79 |
| New patient visit (60+ min) | 13 | $2,231 | $172 |
| Ultrasound of heart, follow-up | 12 | $1,543 | $119 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 26 | $1,491 | $55 |
| Influenza vaccine split virus, preservative free | 14 | $516 | $37 |
| Blood test, clotting time | 55 | $515 | $5 |
| External ekg recording for more than 48 hours up to 21 days | 17 | $464 | $27 |
| Administration of influenza virus vaccine | 14 | $419 | $30 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 17 | $402 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $241 | $19 |
| Injection, dobutamine hydrochloride, per 250 mg | 12 | $51 | None |
2015: 12 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 116 | $27,621 | $238 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 72 | $20,267 | $281 |
| Short return visit (20+ min) | 141 | $18,980 | $65 |
| New patient visit (45+ min) | 117 | $17,335 | $148 |
| Return visit (30+ min) | 76 | $10,766 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $6,089 | $65 |
| Long return visit (40+ min) | 32 | $4,160 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,909 | $178 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,220 | $123 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $719 | $55 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $623 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $305 | $28 |
2014: 1 service
| New patient visit (45+ min) | 38 | $5,533 | $146 |
2013: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,254 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $4,055 | $84 |
Medicaid work
$101 in 2021
Medicaid paid $101 for 37 billed services this clinician did in 2021, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 24 | $52 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $49 |
| 2021 | 37 | 2 | 13 | $101 |
| 2019 | 44 | 2 | 17 | $276 |
| 2018 | 51 | 1 | 14 | $237 |
See the largest Medicaid services in earlier years
2019
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 29 | $164 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $112 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 51 | $237 |
Drugs they prescribed that Part D paid
$852,882
Pharmacies billed $852,882 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,024) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
3,395 generic and fewer than 11 brand-name prescriptions · $852,882 in drug cost · 16 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 372 | $556,669 | $1,496 |
| Xarelto | 93 | $114,819 | $1,235 |
| Jardiance | 24 | $38,714 | $1,613 |
| Entresto | 23 | $27,624 | $1,201 |
| Metoprolol | 352 | $5,715 | $16 |
See all 34 drugs
| Eliquis | 372 | $556,669 | $1,496 |
| Xarelto | 93 | $114,819 | $1,235 |
| Jardiance | 24 | $38,714 | $1,613 |
| Entresto | 23 | $27,624 | $1,201 |
| Metoprolol | 352 | $5,715 | $16 |
| Rosuvastatin | 308 | $5,455 | $18 |
| Atorvastatin | 511 | $4,753 | $9 |
| Amlodipine Besylate | 397 | $2,942 | $7 |
| Valsartan | 118 | $2,815 | $24 |
| Losartan | 193 | $2,228 | $12 |
| Carvedilol | 183 | $1,934 | $11 |
| Diltiazem 24hr Er (Cd) | 64 | $1,649 | $26 |
| Ezetimibe | 39 | $1,555 | $40 |
| Digoxin | 24 | $1,343 | $56 |
| Bumetanide | 18 | $1,191 | $66 |
| Lisinopril | 148 | $1,017 | $7 |
| Furosemide | 218 | $1,009 | $5 |
| Spironolactone | 94 | $936 | $10 |
| Metoprolol | 121 | $785 | $6 |
| Pravastatin | 41 | $782 | $19 |
| Potassium Chloride | 30 | $571 | $19 |
| Clopidogrel | 51 | $553 | $11 |
| Felodipine Er | 13 | $472 | $36 |
| Diltiazem 24hr Er | 12 | $445 | $37 |
| Hydrochlorothiazide | 106 | $429 | $4 |
| Irbesartan | 25 | $354 | $14 |
| Amiodarone | 16 | $339 | $21 |
| Nitroglycerin | 27 | $332 | $12 |
| Atenolol | 33 | $228 | $7 |
| Losartan-Hydrochlorothiazide | 26 | $226 | $9 |
| Hydralazine | 26 | $225 | $9 |
| Warfarin | 22 | $222 | $10 |
| Isosorbide Mononitrate Er | 20 | $165 | $8 |
| Benazepril | 15 | $98 | $7 |
Year by year
| 2024 | 4,024 | 497 | 0% (0) | None | $852,882 |
| 2023 | 3,694 | 446 | 0% (0) | 15% | $787,979 |
| 2022 | 3,426 | 441 | 0% (0) | 13% | $629,516 |
| 2021 | 3,229 | 407 | 0% (0) | 14% | $542,857 |
| 2020 | 2,908 | 376 | 0% (0) | 14% | $443,684 |
| 2019 | 2,727 | 357 | 0% (0) | 16% | $370,763 |
| 2018 | 2,438 | 340 | 0% (0) | 16% | $294,634 |
| 2017 | 1,863 | 262 | 0% (0) | 16% | $159,135 |
| 2016 | 1,253 | 198 | 0% (0) | 22% | $100,133 |
| 2015 | 625 | 105 | 0% (0) | 26% | $34,676 |
| 2014 | 57 | 24 | 0% (0) | 44% | $742 |
| 2013 | 23 | None | 0% (0) | 52% | $2,468 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Eliquis | 321 | $475,547 | $1,481 |
| Xarelto | 71 | $94,397 | $1,330 |
| Jardiance | 19 | $35,801 | $1,884 |
| Entresto | 21 | $34,264 | $1,632 |
| Valsartan | 117 | $8,141 | $70 |
| Rosuvastatin | 227 | $6,741 | $30 |
| Atorvastatin | 448 | $6,602 | $15 |
| Metoprolol | 303 | $5,941 | $20 |
| Amlodipine Besylate | 399 | $3,898 | $10 |
| Losartan | 175 | $2,734 | $16 |
| Bumetanide | 31 | $2,692 | $87 |
| Ezetimibe | 24 | $2,298 | $96 |
| Carvedilol | 167 | $2,265 | $14 |
| Diltiazem 24hr Er (Cd) | 54 | $1,708 | $32 |
| Lisinopril | 156 | $1,634 | $10 |
| Metoprolol | 131 | $1,500 | $11 |
| Verapamil Sr | 12 | $1,416 | $118 |
| Potassium Chloride | 35 | $1,218 | $35 |
| Furosemide | 177 | $1,150 | $6 |
| Digoxin | 23 | $1,119 | $49 |
| Clopidogrel | 60 | $1,023 | $17 |
| Spironolactone | 82 | $947 | $12 |
| Pravastatin | 39 | $701 | $18 |
| Losartan-Hydrochlorothiazide | 36 | $667 | $19 |
| Isosorbide Mononitrate Er | 25 | $622 | $25 |
| Irbesartan | 17 | $511 | $30 |
| Hydrochlorothiazide | 111 | $495 | $4 |
| Nitroglycerin | 30 | $484 | $16 |
| Atenolol | 41 | $431 | $11 |
| Pantoprazole | 12 | $424 | $35 |
| Lovastatin | 16 | $371 | $23 |
| Hydralazine | 26 | $336 | $13 |
| Amiodarone | 14 | $316 | $23 |
| Benazepril | 20 | $279 | $14 |
| Warfarin | 16 | $193 | $12 |
2022: 36 drugs
| Eliquis | 297 | $413,980 | $1,394 |
| Xarelto | 38 | $55,454 | $1,459 |
| Entresto | 12 | $21,658 | $1,805 |
| Multaq | 16 | $15,216 | $951 |
| Valsartan | 121 | $9,783 | $81 |
| Rosuvastatin | 171 | $6,238 | $36 |
| Metoprolol | 232 | $5,005 | $22 |
| Bumetanide | 52 | $4,841 | $93 |
| Atorvastatin | 406 | $4,477 | $11 |
| Amlodipine Besylate | 421 | $3,422 | $8 |
| Diltiazem 24hr Er (Cd) | 59 | $3,152 | $53 |
| Losartan | 176 | $2,690 | $15 |
| Carvedilol | 163 | $2,401 | $15 |
| Ezetimibe | 14 | $1,718 | $123 |
| Digoxin | 29 | $1,662 | $57 |
| Potassium Chloride | 46 | $1,361 | $30 |
| Furosemide | 155 | $1,092 | $7 |
| Diltiazem | 14 | $1,012 | $72 |
| Lisinopril | 157 | $1,011 | $6 |
| Metoprolol | 125 | $947 | $8 |
| Clopidogrel | 53 | $882 | $17 |
| Isosorbide Mononitrate Er | 30 | $791 | $26 |
| Pravastatin | 25 | $756 | $30 |
| Irbesartan | 21 | $723 | $34 |
| Nitroglycerin | 31 | $656 | $21 |
| Spironolactone | 71 | $596 | $8 |
| Losartan-Hydrochlorothiazide | 19 | $508 | $27 |
| Verapamil Er | 12 | $504 | $42 |
| Felodipine Er | 13 | $497 | $38 |
| Warfarin | 23 | $485 | $21 |
| Hydrochlorothiazide | 106 | $375 | $4 |
| Atenolol | 45 | $353 | $8 |
| Benazepril | 16 | $336 | $21 |
| Hydralazine | 22 | $234 | $11 |
| Lovastatin | 14 | $233 | $17 |
| Simvastatin | 15 | $126 | $8 |
2021: 37 drugs
| Eliquis | 254 | $336,761 | $1,326 |
| Xarelto | 26 | $39,646 | $1,525 |
| Pradaxa | 29 | $30,126 | $1,039 |
| Multaq | 24 | $23,222 | $968 |
| Valsartan | 98 | $7,001 | $71 |
| Rosuvastatin | 145 | $6,958 | $48 |
| Bumetanide | 72 | $6,880 | $96 |
| Metoprolol | 217 | $5,799 | $27 |
| Atorvastatin | 384 | $4,750 | $12 |
| Diltiazem 24hr Er (Cd) | 55 | $3,543 | $64 |
| Amlodipine Besylate | 365 | $2,951 | $8 |
| Carvedilol | 205 | $2,864 | $14 |
| Losartan | 178 | $2,720 | $15 |
| Potassium Chloride | 39 | $1,639 | $42 |
| Digoxin | 22 | $1,578 | $72 |
| Ezetimibe | 16 | $1,575 | $98 |
| Diltiazem | 16 | $1,523 | $95 |
| Metoprolol | 115 | $1,384 | $12 |
| Pravastatin | 40 | $1,253 | $31 |
| Flecainide Acetate | 11 | $1,199 | $109 |
| Lisinopril | 158 | $978 | $6 |
| Losartan-Hydrochlorothiazide | 19 | $890 | $47 |
| Irbesartan | 20 | $821 | $41 |
| Isosorbide Mononitrate Er | 24 | $715 | $30 |
| Furosemide | 128 | $706 | $6 |
| Verapamil Er | 18 | $685 | $38 |
| Clopidogrel | 37 | $581 | $16 |
| Spironolactone | 39 | $502 | $13 |
| Hydralazine | 31 | $489 | $16 |
| Warfarin | 29 | $473 | $16 |
| Hydrochlorothiazide | 99 | $355 | $4 |
| Pantoprazole | 15 | $319 | $21 |
| Atenolol | 37 | $254 | $7 |
| Lovastatin | 20 | $254 | $13 |
| Benazepril | 15 | $219 | $15 |
| Nitroglycerin | 13 | $186 | $14 |
| Simvastatin | 22 | $128 | $6 |
2020: 37 drugs
| Eliquis | 204 | $247,472 | $1,213 |
| Xarelto | 30 | $37,811 | $1,260 |
| Multaq | 18 | $21,431 | $1,191 |
| Pradaxa | 20 | $18,147 | $907 |
| Rosuvastatin | 143 | $8,654 | $61 |
| Metoprolol | 211 | $6,757 | $32 |
| Atorvastatin | 368 | $6,160 | $17 |
| Valsartan | 66 | $5,610 | $85 |
| Diltiazem 24hr Er (Cd) | 49 | $5,394 | $110 |
| Bumetanide | 22 | $2,941 | $134 |
| Amlodipine Besylate | 335 | $2,534 | $8 |
| Losartan | 156 | $2,369 | $15 |
| Carvedilol | 179 | $2,145 | $12 |
| Ezetimibe | 12 | $1,960 | $163 |
| Potassium Chloride | 47 | $1,627 | $35 |
| Olmesartan Medoxomil | 20 | $1,395 | $70 |
| Metoprolol | 114 | $1,222 | $11 |
| Losartan-Hydrochlorothiazide | 13 | $1,215 | $93 |
| Clopidogrel | 64 | $1,124 | $18 |
| Pravastatin | 27 | $1,081 | $40 |
| Digoxin | 14 | $1,053 | $75 |
| Irbesartan | 22 | $1,041 | $47 |
| Furosemide | 132 | $1,018 | $8 |
| Lisinopril | 129 | $919 | $7 |
| Verapamil Er | 13 | $903 | $69 |
| Isosorbide Mononitrate Er | 30 | $843 | $28 |
| Diltiazem | 14 | $701 | $50 |
| Warfarin | 36 | $622 | $17 |
| Hydralazine | 28 | $552 | $20 |
| Pantoprazole | 25 | $436 | $17 |
| Spironolactone | 33 | $424 | $13 |
| Nitroglycerin | 19 | $400 | $21 |
| Cartia Xt | 12 | $396 | $33 |
| Atenolol | 27 | $336 | $12 |
| Hydrochlorothiazide | 74 | $294 | $4 |
| Benazepril | 18 | $244 | $14 |
| Lovastatin | 18 | $233 | $13 |
2019: 38 drugs
| Eliquis | 185 | $197,849 | $1,069 |
| Xarelto | 23 | $23,323 | $1,014 |
| Pradaxa | 29 | $20,073 | $692 |
| Multaq | 16 | $15,491 | $968 |
| Rosuvastatin | 102 | $8,514 | $83 |
| Metoprolol | 181 | $6,474 | $36 |
| Atorvastatin | 357 | $6,238 | $17 |
| Bumetanide | 15 | $5,073 | $338 |
| Valsartan | 52 | $3,615 | $70 |
| Olmesartan Medoxomil | 34 | $3,334 | $98 |
| Diltiazem 24hr Er (Cd) | 26 | $2,644 | $102 |
| Carvedilol | 157 | $2,215 | $14 |
| Isosorbide Dinitrate | 11 | $2,133 | $194 |
| Amlodipine Besylate | 266 | $2,112 | $8 |
| Ezetimibe | 11 | $1,799 | $164 |
| Potassium Chloride | 34 | $1,431 | $42 |
| Amiodarone | 11 | $1,383 | $126 |
| Losartan | 121 | $1,328 | $11 |
| Furosemide | 147 | $1,167 | $8 |
| Isosorbide Mononitrate Er | 45 | $1,120 | $25 |
| Metoprolol | 130 | $1,046 | $8 |
| Clopidogrel | 69 | $1,027 | $15 |
| Pravastatin | 28 | $960 | $34 |
| Irbesartan | 35 | $918 | $26 |
| Lisinopril | 143 | $798 | $6 |
| Warfarin | 47 | $764 | $16 |
| Hydralazine | 27 | $722 | $27 |
| Verapamil Er | 13 | $682 | $52 |
| Klor-Con 10 | 14 | $633 | $45 |
| Pantoprazole | 26 | $395 | $15 |
| Digoxin | 12 | $389 | $32 |
| Hydrochlorothiazide | 55 | $356 | $6 |
| Losartan-Hydrochlorothiazide | 19 | $269 | $14 |
| Atenolol | 25 | $264 | $11 |
| Lovastatin | 14 | $229 | $16 |
| Spironolactone | 15 | $200 | $13 |
| Benazepril | 20 | $199 | $10 |
| Felodipine Er | 12 | $171 | $14 |
2018: 31 drugs
| Eliquis | 129 | $121,595 | $943 |
| Pradaxa | 23 | $17,566 | $764 |
| Xarelto | 12 | $15,288 | $1,274 |
| Metoprolol | 173 | $7,461 | $43 |
| Atorvastatin | 318 | $5,819 | $18 |
| Rosuvastatin | 66 | $4,284 | $65 |
| Diltiazem 24hr Er (Cd) | 22 | $2,515 | $114 |
| Amiodarone | 22 | $2,169 | $99 |
| Valsartan | 26 | $1,713 | $66 |
| Amlodipine Besylate | 222 | $1,657 | $7 |
| Olmesartan Medoxomil | 19 | $1,550 | $82 |
| Carvedilol | 139 | $1,376 | $10 |
| Losartan | 125 | $1,283 | $10 |
| Hydralazine | 42 | $1,200 | $29 |
| Furosemide | 160 | $1,120 | $7 |
| Potassium Chloride | 31 | $1,052 | $34 |
| Isosorbide Mononitrate Er | 40 | $1,041 | $26 |
| Clopidogrel | 74 | $999 | $13 |
| Warfarin | 58 | $980 | $17 |
| Lisinopril | 170 | $962 | $6 |
| Pravastatin | 31 | $775 | $25 |
| Metoprolol | 98 | $642 | $7 |
| Atenolol | 31 | $427 | $14 |
| Hydrochlorothiazide | 55 | $392 | $7 |
| Cartia Xt | 11 | $382 | $35 |
| Nitroglycerin | 16 | $317 | $20 |
| Losartan-Hydrochlorothiazide | 18 | $264 | $15 |
| Lovastatin | 13 | $202 | $16 |
| Spironolactone | 17 | $199 | $12 |
| Benazepril | 21 | $179 | $9 |
| Pantoprazole | 15 | $133 | $9 |
2017: 29 drugs
| Eliquis | 70 | $66,237 | $946 |
| Xarelto | 11 | $11,886 | $1,081 |
| Pradaxa | 14 | $8,412 | $601 |
| Atorvastatin | 248 | $5,336 | $22 |
| Metoprolol | 119 | $4,276 | $36 |
| Rosuvastatin | 23 | $2,334 | $101 |
| Valsartan | 20 | $1,461 | $73 |
| Amlodipine Besylate | 219 | $1,454 | $7 |
| Carvedilol | 141 | $1,407 | $10 |
| Isosorbide Mononitrate Er | 32 | $1,213 | $38 |
| Hydralazine | 28 | $1,136 | $41 |
| Amiodarone | 19 | $1,070 | $56 |
| Potassium Chloride | 26 | $835 | $32 |
| Lisinopril | 115 | $810 | $7 |
| Pravastatin | 26 | $738 | $28 |
| Losartan | 79 | $732 | $9 |
| Warfarin | 43 | $710 | $17 |
| Clopidogrel | 56 | $673 | $12 |
| Furosemide | 103 | $652 | $6 |
| Diltiazem 24hr Er | 15 | $565 | $38 |
| Metoprolol | 77 | $405 | $5 |
| Atenolol | 35 | $402 | $11 |
| Nitroglycerin | 11 | $270 | $25 |
| Hydrochlorothiazide | 36 | $196 | $5 |
| Spironolactone | 16 | $169 | $11 |
| Simvastatin | 29 | $167 | $6 |
| Losartan-Hydrochlorothiazide | 11 | $135 | $12 |
| Benazepril | 15 | $125 | $8 |
| Lovastatin | 11 | $112 | $10 |
2016: 22 drugs
| Eliquis | 50 | $32,506 | $650 |
| Multaq | 20 | $13,375 | $669 |
| Xarelto | 21 | $8,774 | $418 |
| Atorvastatin | 135 | $2,534 | $19 |
| Metoprolol | 51 | $1,888 | $37 |
| Amlodipine Besylate | 116 | $994 | $9 |
| Potassium Chloride | 31 | $823 | $27 |
| Carvedilol | 93 | $799 | $9 |
| Isosorbide Mononitrate Er | 20 | $748 | $37 |
| Lisinopril | 89 | $671 | $8 |
| Losartan | 51 | $593 | $12 |
| Clopidogrel | 28 | $540 | $19 |
| Atenolol | 30 | $539 | $18 |
| Diltiazem 24hr Er | 13 | $516 | $40 |
| Furosemide | 102 | $512 | $5 |
| Diltiazem Er | 12 | $500 | $42 |
| Metoprolol | 76 | $454 | $6 |
| Warfarin | 30 | $450 | $15 |
| Pravastatin | 14 | $434 | $31 |
| Nitrostat | 14 | $363 | $26 |
| Simvastatin | 39 | $284 | $7 |
| Clonidine | 11 | $98 | $9 |
2015: 18 drugs
| Eliquis | 13 | $6,929 | $533 |
| Xarelto | 11 | $4,087 | $372 |
| Atorvastatin | 76 | $1,249 | $16 |
| Metoprolol | 20 | $901 | $45 |
| Furosemide | 67 | $385 | $6 |
| Isosorbide Mononitrate Er | 18 | $382 | $21 |
| Amlodipine Besylate | 44 | $371 | $8 |
| Carvedilol | 60 | $304 | $5 |
| Pravastatin | 12 | $302 | $25 |
| Atenolol | 25 | $264 | $11 |
| Potassium Chloride | 14 | $262 | $19 |
| Nitrostat | 15 | $259 | $17 |
| Losartan | 27 | $258 | $10 |
| Metoprolol | 47 | $236 | $5 |
| Clopidogrel | 13 | $214 | $16 |
| Lisinopril | 35 | $193 | $6 |
| Warfarin | 14 | $127 | $9 |
| Benazepril | 11 | $52 | $5 |
2014: 1 drug
| Atorvastatin | 16 | $105 | $7 |
Money from drug and device companies
$20 in 2021
| 2021 | 1 | 1 | None | $20 |
| 2019 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Mitraclip System | $20 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2021-05-20 | Mitraclip System | $20 |
See earlier years (2019)
2019: $17
| Lantheus Medical Imaging | Definity | $17 | 1 payment
|
Professional record
- NPI
- 1770735326
- Licence
- CA A110953California A110953: Current · expires 2027-11-30
- Trained
- New York Medical College, 2008 · 18 years ago
- Group
- Washington Township Hospital District · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Student in a training program (390200000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2008-10-15
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.